These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31136884)

  • 1. Chemotherapy for gestational trophoblastic neoplasia patients with a FIGO score of 12 or greater: A multistudy analysis.
    Li J; Yue H; Wang X; Chen R; Lu X
    Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():164-169. PubMed ID: 31136884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥5.
    Li Y; Kong Y; Wan X; Feng F; Ren T; Zhao J; Yang J; Xiang Y
    Oncologist; 2021 Dec; 26(12):e2209-e2216. PubMed ID: 34396643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of chemotherapy on ovarian function and quality of life of patients with gestational trophoblastic neoplasia].
    Xue W; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):377-383. PubMed ID: 29961279
    [No Abstract]   [Full Text] [Related]  

  • 4. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
    Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
    [No Abstract]   [Full Text] [Related]  

  • 5. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
    Lurain JR; Schink JC
    J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008891. PubMed ID: 23235667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD008891. PubMed ID: 26760424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.
    Alifrangis C; Agarwal R; Short D; Fisher RA; Sebire NJ; Harvey R; Savage PM; Seckl MJ
    J Clin Oncol; 2013 Jan; 31(2):280-6. PubMed ID: 23233709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first-line treatment of high-risk gestational trophoblastic neoplasia.
    Singh K; Gillett S; Ireson J; Hills A; Tidy JA; Coleman RE; Hancock BW; Winter MC
    Int J Cancer; 2021 May; 148(9):2335-2344. PubMed ID: 33210289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
    Mao Y; Wan X; Lv W; Xie X
    Int J Gynaecol Obstet; 2007 Jul; 98(1):44-7. PubMed ID: 17481633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacies of FAEV and EMA/CO regimens as primary treatment for gestational trophoblastic neoplasia.
    Ji M; Jiang S; Zhao J; Wan X; Feng F; Ren T; Yang J; Xiang Y
    Br J Cancer; 2022 Aug; 127(3):524-530. PubMed ID: 35459802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
    Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
    Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.
    Even C; Pautier P; Duvillard P; Floquet A; Kerbrat P; Troalen F; Rey A; Balleyguier C; Tazi Y; Leary A; Augereau P; Morice P; Droz JP; Fizazi K; Lhommé C
    Eur J Cancer; 2014 Aug; 50(12):2082-9. PubMed ID: 24910417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Curative effects and influenced factors of EMA-CO as an initial regimen for the treatment of high-risk gestational trophoblastic neoplasia].
    Liu W; Zhao W; Zhang YQ; Huang XF
    Zhonghua Yi Xue Za Zhi; 2018 Dec; 98(47):3896-3899. PubMed ID: 30585038
    [No Abstract]   [Full Text] [Related]  

  • 15. Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?
    Essel KG; Bruegl A; Gershenson DM; Ramondetta LM; Naumann RW; Brown J
    Gynecol Oncol; 2017 Jul; 146(1):74-80. PubMed ID: 28473205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy.
    Escobar PF; Lurain JR; Singh DK; Bozorgi K; Fishman DA
    Gynecol Oncol; 2003 Dec; 91(3):552-7. PubMed ID: 14675675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
    Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F
    Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary treatment of stage IV gestational trophoblastic neoplasia with floxuridine, dactinomycin, etoposide and vincristine (FAEV): A report based on our 10-year clinical experiences.
    Yang J; Xiang Y; Wan X; Feng F; Ren T
    Gynecol Oncol; 2016 Oct; 143(1):68-72. PubMed ID: 27426306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptomeningeal disease as a presenting feature of gestational trophoblastic neoplasia: A review and recommendations for management.
    Hapuarachi B; Tidy JA; Romanowski C; Singh K; Gillett S; Ireson J; Winter MC
    Gynecol Oncol; 2023 May; 172():47-53. PubMed ID: 36934478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.
    Cagayan MS
    J Reprod Med; 2012; 57(5-6):231-6. PubMed ID: 22696818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.